Gene description for ERBB2 |
Gene name |
erb-b2 receptor tyrosine kinase 2 |
Gene symbol |
ERBB2 |
Other names/aliases |
CD340 HER-2 HER-2/neu HER2 MLN 19 MLN-19 NEU NGL TKR1 VSCN2 c-ERB-2 c-ERB2 p185(erbB2) |
Species |
Homo sapiens |
Experiment description of studies that identified ERBB2 in Ascites |
1
|
Experiment ID | 56 |
Identified molecule | protein
|
Extracellular vesicle type | Exosomes |
MISEV | EVs |
Identification method | Western blotting
|
PubMed ID |
12147373
|
Organism | Homo sapiens |
Experiment description | Malignant effusions and immunogenic tumour-derived exosomes. |
Authors | Andre F, Schartz NE, Movassagh M, Flament C, Pautier P, Morice P, Pomel C, Lhomme C, Escudier B, Le Chevalier T, Tursz T, Amigorena S, Raposo G, Angevin E, Zitvogel L |
Journal name |
LANCET
|
Publication year | 2002 |
Sample | Ascites |
Sample name | Malignant ascites |
Isolation/purification methods | Differential centrifugation Sucrose density gradient |
Flotation density | 1.14-1.18 g/mL |
Molecules identified in the study | Protein |
Methods used in the study | Western blotting |
EV-TRACK |
-
|
|
|
2
|
Experiment ID | 238 |
Identified molecule | protein
|
Extracellular vesicle type | Exosomes |
MISEV | EVs |
Identification method | Dot blot
|
PubMed ID |
21293856
|
Organism | Homo sapiens |
Experiment description | Tumour exosomes inhibit binding of tumour-reactive antibodies to tumour cells and reduce ADCC |
Authors | Battke C, Ruiss R, Welsch U, Wimberger P, Lang S, Jochum S, Zeidler R |
Journal name |
Cancer Immunol Immunother
|
Publication year | 2011 |
Sample | Ascites |
Sample name | Malignant ascites - Ovarian cancer |
Isolation/purification methods | Differential centrifugation Filtration Ultrafiltration Ultracentrifugation Sucrose density gradient |
Flotation density | 1.13-1.17 g/mL |
Molecules identified in the study | Protein |
Methods used in the study | Dot blot |
EV-TRACK |
EV110080: EV-METRIC:14%, 14%, 38%
|
|
|